Quantcast
Last updated on April 24, 2014 at 1:21 EDT

Latest radiopharmaceuticals Stories

2014-04-17 16:26:59

Lumiphore Inc., a pharmaceutical leader in bifunctional chelator design, is developing in vivo radio-diagnostic imaging and site-directed radio-therapeutics, using its proprietary bifunctional radionuclide metal-chelation technology; it has received a National Science Foundation Small Business Innovation Research (SBIR) Phase II Grant entitled "Novel macrocyclic chelating groups for use in targeted radioisotope diagnostic and companion diagnostic/therapeutic applications." BERKELEY,...

2014-04-09 16:25:48

MONTREAL, April 9, 2014 /PRNewswire/ - Jubilant DraxImage Inc., a Jubilant Life Sciences Company, is pleased to announce the appointment of Mr. Michael Rossi as Vice President, Sales and Business Operations, Jubilant DraxImage Inc., with effect from the 21(st) April 2014. Mr. Rossi has worked for GE Healthcare, Life Sciences since 2002, and currently holds the position of General Manager, Global SPECT Business. During his tenure with GE, he has led several commercial organizations...

2014-04-04 12:27:22

Long term supply agreement signed MONONA, Wis., April 4, 2014 /PRNewswire-iReach/ -- SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in safe, clean, affordable production of medical isotopes, announced today that it has entered into a strategic long-term supply agreement with GE Healthcare, a division of the General Electric Company, for supply of molybdenum-99 (moly-99). This is the first announcement of a major supply...

2014-03-31 20:21:45

DUBLIN, April 1, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/c3vlm5/global) has announced the addition of the "Global Radiopharmaceuticals Market Insight" [http://www.researchandmarkets.com/research/c3vlm5/global ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Radioisotopes are radioactive isotopes having an unstable balance of atomic nucleus. Radioisotopes are produced either by...

2014-03-26 16:25:57

LONDON, March 26, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Global Radiopharmaceutical Market 2012-2016 TechNavio's analysts forecast the Global Radio Pharmaceutical market to grow at a CAGR of 18.39 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing aging population. The Global Radio Pharmaceutical market has also been witnessing the increasing demand for radiopharmaceuticals....

2014-03-23 23:00:43

RnRMarketResearch.com adds Latest Report on “Global Radiopharmaceuticals Market Insight” to its store. Dallas, TX (PRWEB) March 23, 2014 “Purchase the report for 20% discount. Offer valid until 31st March 2014″. Radioisotopes are radioactive isotopes having an unstable balance of atomic nucleus. Radioisotopes are produced either by using nuclear research reactor or by using cyclotron. These isotopes emit energy in the form of alpha, beta or gamma when changed to a stable nature....

2014-03-13 23:25:08

Opportunities for developments, mergers and acquisitions, and investments are just ahead. Louvain-la-Neuve, Belgium, and Lalaye, France (PRWEB) March 13, 2014 This is world's first comprehensive evaluation report and directory of nuclear medicine, written by experts, provides detailed information on products and companies active in this market. It is an almost 800-page report including descriptions of over 300 radiopharmaceuticals and radionuclides and more than 130 detailed profiles...

2014-03-04 08:31:27

SAINT-GENIS-POUILLY, France, March 4, 2014 /PRNewswire/ -- Advanced Accelerator Applications (AAA), a fast growing international player in Molecular Nuclear Medicine (MNM), announced today that they have received orphan drug designation status for their radiopharmaceutical, Gallium-68 DOTATATE. The orphan drug designation has been granted by both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for use of Gallium-68 DOTATATE as a diagnostic...

2014-02-12 12:32:02

DUBLIN, Feb. 12, 2014 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/cn9qz8/nuclear_medicine) has announced the addition of the "Concise Analysis of the International Nuclear Medicine Market & Radiopharmaceuticals - Trends & Forecast to 2017" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Radiopharmaceuticals are drugs that contain radionuclide-emitting ionizing radiation and are used for disease diagnosis and...

2014-01-26 23:01:46

Nuclear Medicine / Radiopharmaceuticals Market report broken down into segments and sub-segments, providing exhaustive value analysis for the years 2010, 2011, 2012 and forecast to 2017. http://www.marketsandmarkets.com/Market-Reports/european-nuclear-medicine-radiopharmaceuticals-market-1107.html (PRWEB) January 26, 2014 The “European SPECT/PET Radioisotopes (Technetium, F-18)], Beta/Alpha Radiation Therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & (Deuterium,...